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Abstract
Epsilon toxin is a potent neurotoxin produced by Clostridium perfringens types B and D, an anaerobic bacterium that causes
enterotoxaemia in ruminants. In the affected animal, it causes oedema of the lungs and brain by damaging the endothelial
cells, inducing physiological and morphological changes. Although it is believed to compromise the intestinal barrier, thus
entering the gut vasculature, little is known about the mechanism underlying this process. This study characterizes the
effects of epsilon toxin on fluid transport and bioelectrical parameters in the small intestine of mice and rats. The
enteropooling and the intestinal loop tests, together with the single-pass perfusion assay and in vitro and ex vivo analysis in
Ussing’s chamber, were all used in combination with histological and ultrastructural analysis of mice and rat small intestine,
challenged with or without C. perfringens epsilon toxin. Luminal epsilon toxin induced a time and concentration dependent
intestinal fluid accumulation and fall of the transepithelial resistance. Although no evident histological changes were
observed, opening of the mucosa tight junction in combination with apoptotic changes in the lamina propria were seen
with transmission electron microscopy. These results indicate that C. perfringens epsilon toxin alters the intestinal
permeability, predominantly by opening the mucosa tight junction, increasing its permeability to macromolecules, and
inducing further degenerative changes in the lamina propria of the bowel.
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Introduction
Epsilon toxin (ETX) produced by Clostridium perfringens types B and
D is responsible for a highly fatal enterotoxaemia in livestock [1]. This
toxin is secreted in the gut lumen as a prototoxin which then becomes
fully active by the action of either the host’s intestinal trypsin or a C.
perfringens metalloproteinase [2]. Once fully activated, ETX is
absorbed and spreads through the blood-stream, affecting the lungs,
kidneys and the brain [3]. Sheep and goats suffering from C. perfringens
type D enterotoxaemia can experience a disease ranging from a
peracute form, with neurological signs and sudden death, to a chronic
intestinal disease, including hemorrhagic diarrhea and colitis [1].
The disease associated with C. perfringens type D in young lambs
is very brief, often less than 2 hours, with many lambs being found
dead without premonitory signs, or dying after a few minutes of
violent convulsive activity [4]. In lambs and goats inoculated
intraduodenally with C. perfringens type D culture supernatant
containing ETX, nervous signs or death were observed as soon as
30 minutes after inoculation [5]. Similarly, in mice, lethal effects
were observed 2 hours after oral administration of ETX [6].
Although this evidence indicates that ETX is promptly absorbed
from the gut lumen into the blood circulation, the mechanism
involving this process is yet unknown.
Experimentally, necrosis of the colonic epithelium is observed in
ETX treated tissues of sheep and goats [7]. This morphological
damage can alter the function of the epithelial barrier, allowing
toxin absorption through the large intestine. However, evident
epithelial damage in the large intestine is rarely seen in natural
cases of acute and peracute enterotoxaemia of sheep, thus
suggesting that other segments of the gastrointestinal tract are
involved in ETX absorption [1]. In fact, Losada-Eaton et al. [8]
showed that ETX can be absorbed from both, the large and small
intestines of experimentally inoculated mice.
Bullen and Batty [9] reported that filtrates containing ETX,
increased immunoglobulin absorption in the intestine of mice and
sheep and Fernandez-Miyakawa et al. [10] observed that
pefringolysin-O, a 54 KDa thiol-activated hemolysin from C.
perfringens, was only absorbed from the intestinal tract of mice when
ETX was present, but in the absence of histological damage to the
intestine. These results suggest that ETX affects the small intestinal
permeability by a mechanism independent on histological damage.
ETX has the ability to induce water accumulation in the small
intestine of sheep and goats [7]. This fluid imbalance may explain the
diarrhea or watery intestinal contents observed in C. perfringens type D
enterotoxaemia, particularly if the animals survive longer than a few
hours [4,11]. However, the physio-pathological mechanisms of fluid
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imbalance induced by ETX in the small intestine are unknown [12].
An augmented paracellular permeability of the small intestine could
be responsible not only for the toxin absorption; it could be
responsible, at least in part, for the fluid accumulation observed in the
small intestine of sheep and goats. However, the available data to
support this hypothesis is not only scanty but indirect.
In an attempt to address these issues, the aims of the present study
were as follows: (i) to assess whether ETX can induce changes in the
fluid transport of the mouse small intestine (ii) to investigate the
effects of ETX on the electrophysiological parameters of the small
intestine in vitro and ex vivo, and (iii) to determine whether ETX-
induced intestinal changes alters epithelial permeability.
Results
Effects of ETX on intestinal fluid
Intestinal fluid accumulation in the mouse small intestine was
initially determined by the enteropooling assay. Figure 1A shows
an experiment carried out to confirm the ability of the
enteropooling assay to evaluate enterotoxicity with C. botulinum
C2 toxin, used as a validated intestinal control model. The results
of this experiment show that C. botulinum C2 toxin, which had been
previously described to have enterotoxic effects in the intestine of
mice, produced fluid accumulation dependent of the toxin
concentration 6 hours after the toxin was orally administered.
Figure 1. C. perfringens epsilon toxin alters fluid homeostasis in the small intestine. (A) The enteropooling assay detected small intestinal
fluid accumulation induced by luminal enterotoxin. Groups of 4 mice were orally administered with different doses of C. botulinum C2 toxin and
intestinal fluid was determined 6 hours after oral administration. The results shown are the mean6standard error of the mean. (B) Epsilon toxin of C.
perfringens altered fluid homeostasis in the mouse small intestine. Enteropooling was measured in groups of 4 mice treated with toxin (1,000 LD50) or
vehicle solution 2 and 6 h after oral administration. The results are expressed as the mean6standard error of the mean. (C) Epsilon toxin of C.
perfringens produced fluid accumulation in mouse intestinal loops. Vehicle solution with or without 1,000 LD50 of toxin were injected in ligated ileal
segments. The loops were excised 3 hours after injection of the toxin and intestinal water was determined gravimetrically. Each point represents the
mean6standard error. (D) Basal absorption of water by the mouse small intestine was diminished by C. perfringens epsilon toxin when measured by
the single-pass perfusion method. Perfusion began with an equilibration period of 45 min. Then, Ringer solution containing 500 LD50/ml of epsilon
toxin or Ringer solution alone was perfused and after 60 minutes four 15-min samples were collected. The volume of each sample was determined.
Each mouse was killed at the end of the perfusion, and the segment of jejunum was removed and its length measured. The absorbed or secreted
volume was calculated as collected volume minus perfused volume and expressed per centimeter of perfused bowel per minute. Data were
relativized to the value obtained at time 15. Changes become statistically significant after 45 minutes of toxin delivery (P,0.05).
doi:10.1371/journal.pone.0007065.g001
Intestinal Epsilon Toxin
PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7065
The effects of ETX in the intestine of mice were then evaluated
following the same experimental protocol. Figure 1B shows that
intestinal fluid values was about 3 times greater than control 6 h
after toxin delivery (Fig. 2, P,0.05). This increased fluid
accumulation was observed as soon as two hour after toxin
ingestion (Fig. 1B, P,0.05) and this effect was dependent of toxin
concentration (Table 1). These ETX effects in the fluid transport
were confirmed when 1,000 lethal dose fifity (LD50)/ml were
incubated in ligated ileal loops during 3 h (Fig. 1C, P,0.05). Also,
the water transport was affected in jejunum when the intestinal
segments were incubated with 500 LD50/ml and changes were
measured by the single-pass perfusion technique (Fig. 1D).
Changes became statistically significant after 45 minutes of toxin
delivery (P,0.05).
The effects of systemic ETX in the enteropooling assay were
further studied. ETX was administered intravenously in mice and
enteropooling was evaluated 3 hours later. A reduction in fluid
accumulation dependent of the toxin concentration was observed
(Table 2). Although the small intestine length was reduced when
ETX was administered orally, this effect was not observed when
this toxin was injected systemically (Table 1 and 2).
In vitro effects of ETX on the electrical parameters of
mouse ileum
Ileal segments of mice mounted in Ussing-type chambers were
incubated with ETX. The basal electrical parameters were not
altered when concentrations up to 8,000 LD50/mL were incubat-
ed in vitro during 60 minutes in the mucosal side of the intestinal
tissues (Fig. 2A and 2B). However, when 30 LD50 of ETX were
incubated in the serosal side, a statistically significant decrease of
the transepithelial resistance (Fig. 2C) was observed after 40
minutes of incubation (P,0.05).
Addition of glucose at the end of the experiments showed
equivalent responses in treated and untreated tissues, indicating
that glucose-Na+ active cotransport function was unaffected.
Ex vivo effects of ETX on the electrical parameters of
mouse ileum
Segments of ileal loops treated during 3 h with different
concentrations of ETX and then mounted ex-vivo in a modified
Ussing chamber showed alterations of PD, Isc and Rt. A slight
increase of Isc was observed when 1,000 LD50 or 2,000 LD50 were
inoculated in ileal loops; those changes became statistically
significant with 4,000 LD50 or 8,000 LD50 (Fig. 3A, P,0.05). A
drop of Rt was evident when 2,000 LD50 or higher toxin
concentrations were used (Fig. 3B, P,0.05). Glucose was added to
the mucosal side after the electrical parameters were stabilized. An
increase of glucose induced-Isc was observed at higher ETX doses
(Fig. 3C). Theophylline stimulated the Isc when it was applied in
the serosal side (Fig. 3D).
The same ex-vivo protocol was used with ileal loops incubated
with 1,000 LD50 of ETX during different periods of time. An
increase of Isc was observed in loops incubated with ETX at 120 or
240 minutes (Fig. 3E, P,0.05). The Rt was significantly reduced
after 120 and 240 minutes of toxin incubation but changes were
not observed with lower incubation times (Fig. 3F, P,0.05). An
increase of glucose induced-Isc was also observed at 240 minutes
when compared to control tisuses (DIsc, 30610 vs
60610 mAmp.cm2, P,0.05). ETX did not produce any significant
alteration of the electrical parameter in the ileum 60 minutes after
4 LD50 were injected intravenously.
Dilution potential
These so called dilution potentials are indicators for the ion
selectivity of the epithelium and changes in these transepithelial
potential differences reflect changes in ion selectivity of the
paracellular pathway if the ion permeability of the cell membranes
remains unaltered. In order to have information about the
permeability of the paracellular pathway we measured the dilution
potential generated when one half of the NaCl in the serosal
solution was substituted with an equimolar amount of mannitol. This
flux produced an increase of the dilution potential difference in
luminal ETX treated ileum (4,000 LD50), indicating that the
Figure 2. In vitro characterization of the effects of C. perfringens
epsilon toxin in the electrical parameters of the murine small
intestine. Epsilon toxin was incubated in the mucosal side of ileal
sheets mounted in modified Ussing chambers. (A) Short circuit current
(Isc) and (B) resistance (Rt) parameters were recorded each 10 minutes in
tissues from 5 mice. (C) Rt values of ileal sheets incubated in the serosal
side with 8,000 LD50/ml of epsilon toxin. Each bar represents results for
4 mice. Results are expressed as means6SEM.
doi:10.1371/journal.pone.0007065.g002
Intestinal Epsilon Toxin
PLoS ONE | www.plosone.org 3 September 2009 | Volume 4 | Issue 9 | e7065
paracellular pathway has a different permeability to Na+ and Cl2,
the permeability of the cation being greater than anion permeability.
The magnitudes of dilution potential were 4.760.2 mV for control
group and 5.860.4 mV for ETX group.
ETX effects on electrical parameters of rat ileum
Basal electrical parameters of ileal segments of rats mounted in
Ussing-type chambers were unaffected by concentrations of toxin
up to 8,000 LD50/mL incubated in the mucosal side for at least 60
minutes. Segments of ileal loops treated with 4,000 LD50 of luminal
ETX during 3 h and then mounted ex-vivo in a modified Ussing
chamber showed alterations of Isc when compared to control loops
(43.565.3y vs 56.265.6) and Rt (67.162.6 vs 54.565.5).
Histological analysis
Although no major histological changes were observed in either
control or epsilon treated loops, in some loops (control and ETX),
mild polymorphonuclear infiltrate was observed in the submucosa
and lamina propria, together with mild shortening of the villi.
Mild oedema was observed in the lamina propria of some ETX
treated loops together with some degenerative cells, exhibiting pycnotic
nuclei. These changes were not observed in the control tissues.
Mucosal binding of ETX in the small intestine
ETX was incubated in ileal loops of mice for 20 minutes and
toxin bound was analyzed by indirect immunofluorescence. ETX
bound to the mucosal epithelium of small intestinal samples
(Fig. 4). No fluorescence was detected in any of the control tissues
analyzed. Binding was observed at the tip, center and base of the
villi. However, the fluorescence intensity in the ETX small
intestine treated samples was higher on the villi than in the crypts.
Passage of molecules through the wall of the
gastrointestinal tract
In the luminal side of the mucosa, HRP could be seen as strong
electrondense deposits. In control mice given HRP intralumenally,
HRP penetrated from the lumen only as far as the zonula
occludens suggesting that the intestinal barrier function was well
maintained (Fig. 5A). Considerable amounts of HRP were seen
between intestinal epithelial cells only in mice treated with ETX,
filtering through the tight junction, from the lumen of the bowel,
towards the lamina propia (Fig. 5B).
The extravasation of Evans blue, which binds with plasma
proteins upon intravenous injection, was examined to see whether
the fluid accumulation and the changes in the intestinal
permeability in vitro is accompanied with the leakage of plasma
protein into the the intestinal lumen. Figure 5C shows the
augmented extravasation of Evans blue 3 h after injection of ETX
into ligated intestinal loops of mice (P,0.05).
Electron microscopy analysis of small intestinal samples
No significant changes were seen in the segments analyzed of
the control loops (Figs. 6A, 7A). In ETX treated loops of rats and
mice, the predominant changes observed were oedema in the
lamina propria (Figs. 6C–E, 7B–C), shrunken cells (Figs. 6C,
7B, D) and cellular debris (Figs. 7B, 6C). Degenerative fibroblasts
(Fig. 6E) and other apoptotic-like cells were frequently seen
(Figs. 7D, E), exhibiting condensed fragmented nucleus and
condensed cytoplasm, sometimes containing degenerated organ-
elles (Fig. 7E). Endothelial cells surrounding apoptotic vascular
cells were frequent (Fig. 6G), and eosinophils (Fig. 7B), plasma cells
and mast cells (Figs. 6F, 7F) were also seen. Some endothelial cells
exhibited degenerative changes, such as irregular nuclear shape
and the blood vessels were often surrounded by oedema and
altered erythrocytes (Fig. 7C).
Discussion
This study aimed to clarify the physiopathology of fluid
accumulation and toxin absorption in the rodent small intestine
exposed to ETX. Previous studies in ruminants (species
naturally affected by ETX) contributed partially to explain the
Table 1. Enteropooling of mice inoculated intragastrically with different ETX concentrations.
Epsilon toxin Dose (LD50) Fluid accumulated (mg/cm) Dried intestine weight (mg) Intestinal length (cm)
0 28.461.6 272610 36.1360.89
125 32.760.4 27665 32.3861.66
500 36.562.9 27968 31.1160.68
2000 38.160.7 266625 29.2160.74
Six mice per treatment were inoculated intragastrically with ETX diluted in 1.5% PBS NaHCO3 solution. Mice were monitored during 3 hours and euthanized at the end
of the experiments. Enteropooling was assessed after removal of the small intestine and determination of wet and dried weight. Final values were relativized to the
intestinal length and expressed as mg/cm.
doi:10.1371/journal.pone.0007065.t001
Table 2. Effect of ETX injected intravenously in mice in the enteropooling values.
Epsilon toxin IV Dose (LD50) Fluid accumulated (mg/cm) Dried intestine weight (mg) Intestinal length (cm)
0 29.161.2 287630 32.3361.17
0.5 25.662.3 273660 31.3361.57
4 22.260.8 288632 35.5861.50
Six mice per treatment were injected intravenously with ETX diluted in peptone water. Mice were monitored during 1 hour and euthanized at the end of the
experiments. Enteropooling was assessed after remotion of the small intestine and determination of wet and dried weight. Final values were relativized to the intestinal
length and expressed as mg/cm.
doi:10.1371/journal.pone.0007065.t002
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changes produced by ETX in the intestinal tract [7,12].
However, since the impracticality to use those species in
determined experimental conditions, rodents were considered
as potential models since the brain lesions in sheep and mice
exposed to ETX are comparable in many respects and the
intravenous and intraperitoneal murine models have frequently
been used to study the pathogenesis of the disease
[13,14,15,16,17,18,19,20]. Although to the best of our knowl-
edge there is not information about natural infection of mice
with C. perfringens type D, a recently developed oral challenge
Figure 3. Ex vivo characterization of the effects of C. perfringens epsilon toxin in the electrical parameters of the murine small
intestine. Intestinal loops were performed in groups of 4–6 anesthetized mice and injected with different concentrations of epsilon toxin in Ringer
solution. In a particular set of experiments, intestines were removed after 3 hours of toxin injection and samples were mounted in Ussing chamber to
measure changes in (A) short circuit current (Isc) and (B) resistance (Rt). Those tissues were exposed to (C) luminal glucose or (D) serosal teophylline
and the Isc changes were recorded. In another set of experiments, ileal loops were injected with 1,000 LD50 of epsilon toxin and incubated during
different periods of time. Values of (E) Isc or (F) Rt were recorded for those intestinal samples. Data are expressed as mean6SEM.
doi:10.1371/journal.pone.0007065.g003
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mouse model for studying C. perfringens type D infection
reproduces some of the clinical findings described in sheep
[6], suggesting that ETX can cross the intestinal barrier. Indeed,
it has been demostrated that purified ETX can be readily
absorbed from the murine small intestine into the systemic
circulation [8].
The small intestine of mice incubated with ETX accumulated
fluid in a concentration-dependent manner when the enteropool-
ing assay was used. The fluid imbalance was corroborated by ileal
loops and intact single-perfusion experiments. The finding suggest
that ETX alters the water homeostasis of the murine small
intestine, despite the absence of significant morphological change
or measurable in vitro bioelectrical alterations, similarly as it was
reported previously for ruminants [7,12]. All of these data support
the use of mice instead sheep or goats to analyse the effects of ETX
by in vivo incubation and posterior electrophysiological in vitro
evaluation.
The first important finding of the present study is that ETX
increases the small intestinal transepithelial permeability, evi-
denced as reduction in the electrical resistance, in both mice and
rats. Transepithelial electrical resistance can be described as
resistance to the passive flow of ions as sodium and chloride. The
two major pathways for such flow are through the apical and
basolateral membranes in series (transcellular) and through the
paracellular space. In epithelia of relatively low resistance, such as
the small intestine, most passive ion flow presumably occurs
through the paracellular space. This electrical resistance reduction
was not due to cell damage since the epithelial cells were
morphologically intact, and glucose-Na+ active co-transport (a
mechanism of transport that occurs only when the tissue is viable)
was responsive. Thus, activity of ETX resulting in decreased
Figure 4. Mucosal ETX binding. Immunofluorescent detection of
ETX (A) was negative in control tissues treated only with the vehicle
solution. (B) ETX (2,000 LD50/ml) treated small intestinal segments gave
a clear signal in the tips of the villi and (C) lower in the crypts.
doi:10.1371/journal.pone.0007065.g004
Figure 5. Epsilon toxin incubated in the small intestine allowed the passage of macromolecules trough the tight junction. (A) HRP
infiltration in the small intestine was not observed beyond the tight junction in control loops of rats and mice. (B and C) In the luminal zone of the
mucosa of ETX treated loops, HRP could be seen as strong electrondense deposits, filtering through the tight junction, from the lumen of the bowel,
towards the chorion (arrows). (D) Extravasation of Evans blue bound to plasma protein was higher in ETX treated animals than control mice.
doi:10.1371/journal.pone.0007065.g005
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transepithelial resistance is likely to do so by decreasing the
resistance of the paracellular pathway. As a consequence of
alteration of the paracellular pathway, the intestinal mucosa
becomes more permeable, and water and electrolytes (under the
force of hydrostatic pressure) leak into the lumen [21]. This
change in transepithelial permeability could be an important
source for fluid imbalance observed in the small intestine of mice,
sheep and goats. The hypothesis is that changes in water transport
may arise from decreased absorption produced by increased
transepithelial permeability. The augmented small intestinal
permeability might be a rather slower process for fluid
accumulation than intestinal secretion and could explain the fact
that diarrhea or watery intestinal contents are observed during
enterotoxaemia particularly if the animals survive longer than a
few hours [4].
The paracellular pathway can be split into two components that
may influence resistance: the tight junction and the remainder of
the paracellular space. The intercellular tight junction is the rate-
limiting barrier in the paracellular pathway for permeation by ions
and larger solutes [22,23]. As the rate-limiting step for paracellular
transit, permeability of the tight junction defines the overall barrier
function of an intact intestinal epithelium and the tight junctions
have a larger conductance for cations [24]. The so-called dilution
potentials are indicators for the ion selectivity of the epithelium
and changes in these transepithelial potential differences reflect
changes in ion selectivity of the paracellular pathway if the ion
permeability of the cell membranes remains unaltered. Alteration
of the dilution potential by ETX can be interpreted as ETX
decreased the cation selectivity of the tight junctions.
Usually, the intestinal barrier is impermeable to microorgan-
isms, particulate antigens and macromolecules as ETX [25].
However, oral administration of ETX produced an increased
passage of immunoglobulins from the intestinal lumen to blood in
mice and sheep [9] and increased lethal absorption of perfringo-
lysin-O (protein monomer 52 kDa) orally administered to mice
[10]. Also, in the present report, the instillation of ETX into ileal
loops resulted in a significant increase in EB recovery when
compared with vehicle-challenged loops, suggesting that the
permeability of the epithelium was affected. Concordant with
the electrophysiology results, it is likely that augmented EB
Figure 6. Transmission electron microscopy of control and epsilon toxin treated small intestinal loops displaying predominantly
edematous changes. In the control loop (A), a blood-vessel exhibiting normal looking endothelial cells and well preserved fibroblast (scale
bar = 2,5 mm). (B) In epsilon treated loops, endothelial cell displaying early degenerative changes, such as irregular nuclear shape are seen adjacent to
apoptotic cells from the lamina propria (scale bar = 2 mm). (C) Platelet aggregation is seen in one vessel, in an area with evident perivascular edema
and irregular-shaped cells (scale bar = 5 mm). (D) a erythrocyte in a vessel is observed surrounded by perivascular edema (scale bar = 7 mm) and (E)
degenerated fibroblast with scattered collagen fibers in the edematous lamina propria are also seen (scale bar = 7 mm). (F) Plasma cell in the proximity
of an apoptotic-like cell (scale bar = 4 mm) (G) and an endothelial cell surrounding a degenerative a degenerative cell.
doi:10.1371/journal.pone.0007065.g006
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recovery was, at least in part, the result of an increased intestinal
epithelial permeability produced by ETX.
The ultrastructural analysis of epsilon treated loops demon-
strated two areas of the ileum which were mostly affected: the
lamina propria and the mucosa. In the lamina propria, oedema
and apoptotic cell-death were the most relevant changes observed.
In the mucosa, on the other hand, subtle opening of the tight
junction, evidenced by the intrusion of the HRP through the
junction, and oedema, evidenced as electronlucent gaps in the
basal area, were the only changes noticed. It is likely that epsilon
toxin is capable of opening the tight junction, increasing the
mucosa permeability to macromolecules. This could enable the
toxin to filter through the mucosa into the lamina propria,
inducing other degenerative and inflammatory changes there. The
toxin appears to alter the vascular permeability as well, thus
inducing oedema. This phenomenon could enable the toxin to
reach the blood stream, causing other systemic alterations.
This study also showed that the basal short-circuit current of
toxin-incubated ileal mucosa ex vivo was increased significantly
when compared with control tissues. Although the source of this
ETX-induced increase in baseline Isc is not clear, it might
contribute to watery intestinal contents in animals suffering the
disease. Also, the addition of luminal glucose or serosal
theophylline revealed significantly higher Isc stimulations in
epithelia from animals pretreated with ETX in comparison with
the control situation. At present it can only be speculated whether
differentiation caused by ETX could account for the findings i.e.
changes in the cytosolic cAMP and/or cGMP concentrations; a
higher number of cells that express enhanced absorptive/secretory
function; an increased density of transporters located in the apical
membrane or by a faster turnover rate of each transporter;
decreased receptor density or enterocyte membrane fluidity
modification.
Immunoflourescence showed a marked binding of ETX to
enterocytes, but it remains unknown if in vivo intestinal activity of
ETX is a direct or an indirect effect of the toxin on epithelial cells.
A few active molecules of ETX overcoming the epithelial barrier
might stimulate mucosal or submucosal components which, in
turn, modulate normal enterocyte function. Correspondingly,
serosal application of ETX in the small intestine produced a drop
of transepithelial resistance. This in vitro decline of electrical
resistance was polar, occurring when the toxin was applicated in
the basolateral rather than the apical surface of the small intestine.
This polarity dependency of ETX induced biological effects may
be due to either, easier access of this toxin to target molecule(s)
localized on the basolateral side of the small intestine, and/or
interaction with a subsequent epithelial factor. Release of
mediators from these cells may conceivably affect the paracrine
Figure 7. Transmission electron microscopy of control and epsilon toxin treated small intestinal loops displaying predominantly
apoptotic-like changes. In control loops (A), enterocytes with normal looking nucleus and organelles are seen (scale bar = 15 mm). In epsilon
treated loops (B) fibroblast with fragmented nucleus and edema with a polymorfonuclear cell (eosinophils) is seen; note as well, the electron lucent
gaps between the epithelial cells (scale bar = 10 mm). (C) Abnormal looking red-blood cells together with degenerating cells, some displaying
organelle and nuclear fragmentation (scale bar = 4 mm, or (D) cytoplasmatic (see in the inlet an apoptotic cell surrounded by another cells in process
of nuclear fragmentation, probably at an early apoptosis stage) and (E) nuclear condensation (scale bar = 10 and 4 mm). (F) Lymphocyte in contact
with a mast-cell (upper-left corner) together with some degenerating fibroblasts (scale bar = 4 mm).
doi:10.1371/journal.pone.0007065.g007
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and/or neural regulation of the epithelium following ETX
administration. The nervous system is considered a primary target
of ETX: it induces damage to neurons in different brain regions
[4] and affects peripheral pathways [15,26]. Other enteric
bacterial toxins are able to activate one or more components of
the enteric nervous system and generate secretory responses [27].
Also, the analysis of the electron microscopy studies do not exclude
pro-inflamatory changes triggered by ETX treatment or endothe-
lial factors related with the ultrastructural changes observed in the
vascular cells.
Direct damage of the endothelium produced by interaction of
ETX with vascular endothelial cells increases the vessel wall
permeability [28]. If ETX absorbed from the intestine causes
necrosis of the endothelial cells, it could alter the intestinal vascular
permeability and consequently the normal physiology of the gut.
Histological analysis of the segments of small intestine exposed to
ETX did not reveal damage to the endothelium, either in mice or
ruminant small intestines [7,29]. However, electron microscopy
analysis revealed that endothelial cells were indeed affected after
4 h of incubation. Gardner [18] found that endothelial cells of
the brain of sheep inoculated intravenously with ETX showed
increased permeability to horseradish peroxidase without
morphological alterations; the later were observed only after a
period of 6 h had elapsed. Moreover, Morgan et al. [19], using
horseradish peroxidase, proved that vascular leakage occurred
several hours before morphological changes were evident in the
brain of mice given an injection of epsilon toxin. Morphological
evidence of degeneration of brain endothelial cells was observed
24 h after the intravenous inoculation of mice with C. perfringens
epsilon toxin [20]. Therefore, it is probably that alteration of
endothelial cells is associated with the physiological imbalance
produced by ETX in the small intestine.
ETX is a highly lethal toxin that induces oedema and
neurological damage. This toxin is responsible of enterotoxaemia
in domestic animals and it is considered a potential bioterrorism
agent. This study suggests that ETX alters small intestinal
homeostasis and allow the paracellular passage of macromolecules
as it was previously observed [9]. The increased epithelial
permeability could be the key factor responsible for the absorption
of lethal concentrations of ETX as well as other toxins produced
during an enterotoxaemia outbreak in ruminants. Some intestinal
luminal nutrients, i.e. glucose present in the small intestine during
enterotoxaemia, may moderate the ETX effects on the fluid
homeostasis. This study shows that ETX destabilizes enterocyte
junction structures but it remains unclear if the toxin directly alters
the epithelial cell or it is a later response. Future studies will
explore these questions and provide further insight into the
pathogenesis of ETX.
Materials and Methods
Animals
Conventionally reared, 20–25 g BALB-c mice and 150–200 g
Wistar rats of either sex were used. The study was approved by the
Animal Care and Use Committee of the University of Buenos
Aires.
Toxin
Purified epsilon prototoxin was prepared from an overnight
culture of C. perfringens type D (strain NCTC 8346) in Trypticase-
yeast-glucose medium, under anaerobic conditions at 37uC. The
overnight cultures were centrifuged at 10,000 rpm for 30 min at
4uC, and the supernatant containing ETX was saved for toxin
purification. The toxin was then precipitated by ammonium
sulfate dialyzed against phosphate buffer solution pH 7.4 (PBS). It
is referred as crude fraction. Two columns were prepared with
DEAE and CM Sepharose (Pharmacia, Sweden), respectively,
equilibrated in 10 mM Tris, pH 7.5. The toxin was applied to the
DEAE column, and the effluent was monitored at 220 nm. The
initially eluted peak was saved and applied to the CM column.
Again the effluent was monitored at 220 nm, and the first peak
was collected, dialyzed against PBS, and freeze-dried. Epsilon
prototoxin purity was checked by SDS-PAGE. Prior to its use in
these experiments, the prototoxin was reconstituted and activated
by incubation at 37uC during 30 min with 0.1% trypsin (Sigma).
Semi-purified Clostridium botulinum C2 toxin was a gift of Dr. Paticia
Geogheghan.
Enteropooling or intraluminal accumulation of fluid
Mucosal transport of fluid was determined using the enter-
opooling assay [30] that evaluates the net accumulation of fluid in
the lumen of the small intestine [31]. After 18 h of fasting and 2 h
of water deprivation, mice were treated as follow. Two groups of 6
mice were dosed orally with 1,000 LD50 of ETX, and sacrificed 2
and 6 h later. Other 4 groups of 6 mice were dosed orally with 0,
125, 500 or 2,000 LD50 of ETX in 0.5 ml of 1.5% PBS NaHCO3.
Further groups of 6 mice were injected intravenously with 4, 0.5 or
0 LD50 of ETX in 0.5 ml of 1% peptone water and analyzed
3 hours later. All of these animals were sacrificed with CO2.
As positive control of the enteropooling assay, groups of 4 mice
were injected intragastrically with 0, 12, 50 and 200 LD50 of C2
botulinum toxin in 0.5 ml of 1.5% PBS NaHCO3 and evaluated
6 hours later. C2 is a recognized enterotoxic clostridial toxin
which induces fluid accumulation in the small intestine of mice
[32]. Mice in negative control group were inoculated with 0.5 ml
of 1.5% PBS NaHCO3.
The small intestine of all the mice was clamped at the pyloric
sphincter and immediately before of the ileo-caecal junction and
carefully removed from the abdomen. The small intestine length
(L) was measured and then weighed (W1), dried of fluid and
reweighed (W2). The difference between W1 and W2 divided by
the length [(W12W2)/L] shows the ‘‘enteropooling’’ in milligrams
of fluid per centimeter of intestine and it is an indication of fluid
accumulation.
Intestinal loop test
Mice were fasted during 18 hs and deprived of water 2 h before
the experiments. The mice were anesthetized by intraperitoneal
injection of 0.5–0.6 g/kg of Tribromoethanol (Avertin). The
abdomen was opened, and starting approximately 2 cm proximal
to the ileo-cecal valve, one loop of 5-cm was isolated with cotton
ligatures on the small intestine. After inoculation of 0.3 ml of PBS
containing 1,000 LD50/ml of ETX and PBS solution as control
the abdomen was closed by applying cyanoacrylate adhesive. The
mice were kept under anesthesia by periodic administration of
avertine until the end of the experiments, 3 h after the inoculation,
when they were killed by cervical dislocation. The intestinal loops
were excised, and the weight and length of each loop were
measured. The net increase in the weight of the loop (in
milligrams) was calculated as a relation between the weight of
the loop inoculated and the length (in centimeters) of the loop.
Perfusion Fluid and Protocol
An in vivo perfusion method for measuring the absorption of
water by the mouse small intestine previously described was
followed with slight modifications [33]. Briefly, ,10 cm small
intestinal loops were constructed as described above. One group to
test ETX and one control group (4 mice each) were used. A
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polyethylene perfusion catheter was inserted into the gut just
below the proximal ligature and secured in place by a silk ligature.
A collecting cannula was inserted into the lumen of the jejunum
10 cm further down to collect the perfusion fluid. The abdominal
wall was closed with three sewing points of 4–0 silk. The isolated
segment of small intestine was quickly rinsed with perfusion fluid,
the input catheter was attached to a perfusion pump (Minipuls II,
Gilson Instruments, speed 80, Technico, producing a flow of
,2 ml/15 min), and 15-min samples were collected from the
output catheter. The perfusion fluid was a Ringer solution
containing (in mM) 115 NaCl, 4 K2HPO4, 0.4 KH2PO4, 25
NaHCO3, 1.2 MgCl2, and 1.2 CaCl2, pH 7.4 and glucose was
added at 10 mM. This solution was pre-warmed at 37uC before
reach the intestinal lumen. Perfusion began with an equilibration
period of 45 min; these samples were discarded. Crude fraction of
ETX (500 LD50/ml) in Ringer solution or Ringer solution alone
was perfused and after 60 minutes four 15-min samples were
collected. The volume of each sample was determined by weight
(assuming that 1 ml = 1 g). The actual input volume was
determined before each perfusion by averaging the weight of
three 15-min samples directly from the pump. The absorbed or
secreted volume was calculated as collected volume minus
perfused volume and expressed per centimeter of perfused bowel
per minute. Fluid transport rate at time ‘‘x’’ was calculated as
Volume tx–Volume t15. Each mouse was killed at the end of the
perfusion, and the segment of jejunum was removed and its length
measured.
Bioelectric Measurements
The effects of ETX in the mouse intestinal electric parameters
were analyzed in vitro and ex vivo. For in vitro experiments, segments
of ileum were obtained from normal mice which were fasted for a
minimum of 2 h and only water was provided. For ex vivo
experiments, ileal loops were performed as described above,
except that loop length was 1,5 cm and the volume injected was
0,1 ml. The mice were killed by a brief exposure to a 100% CO2
gas atmosphere (to induce narcosis) and a midline abdominal
incision was used to excise the ileum. The excised segment was
flushed of any intestinal content with cold saline solution and
opened along the mesenteric border in ice cold-oxygenated Ringer
solution. Each intestinal sheet (1 cm in length) without any visible
Peyer’s patch with a support of nylon gauze were mounted in
modified Ussing chambers (Warner instruments, CA) with an
exposed surface area of 0.25 cm2 and maintained at 37uC by
water-jacketed reservoirs. The tissue sheets were independently
bathed on the serosal and mucosal surfaces with 3 ml of Ringer
solution. Glucose (10 mM) was included in the serosal solution and
10 mM mannitol was substituted for glucose in the mucosal bath
to prevent Na+-coupled glucose current stimulation. Solutions
were gassed with 95% O2–5% CO2. Transmural short circuit
current (Isc, in mA/cm
2 tissue surface area) was measured with the
use of an automatic voltage clamp device (EC-800; Warner
Instruments, CA) that compensates for electrode offset and the
fluid resistance between the potential-measuring electrode bridges.
Transepithelial potential difference (PD, in mV) was measured via
a pair of Silver electrodes connected to the serosal and mucosal
baths by 4% agar-Ringer (wt/vol) bridges. Isc was applied across
the tissue via a pair of Ag/AgCl electrodes that were kept in
contact with the serosal and mucosal baths through 4% agar-
Ringer bridges. All experiments were carried out under short-
circuited conditions. Total transepithelial electrical resistance (Rt,
in V.cm2 tissue surface area) was calculated by applying Ohm’s
law to the current deflection resulting from a 2-mV bipolar pulse
across the tissue every 10 min during the course of the experiment.
In all cases, the serosal side served as ground and the Isc was
conventionally referred to as negative when current flowed from
the lumen to the serosa.
For in vitro studies, the intestinal segments mounted in modified
Ussing chambers were exposed to different concentration of ETX
after a brief period of stabilization and monitored during 60
minutes. In ex vivo experiments, after the tissues achieved a stable
Isc (,30 min), the small intestine preparations were sequentially
exposed to mucosal glucose (10 mM), serosal teophylline (10 mM),
fresh mucosal and serosal Ringer solution, mucosal diluted Ringer
solution. At the end of any experiment, glucose (10 mM) was
added to the luminal bath of the small intestinal preparations as
measures of tissue viability. For in vitro experiments, results are
expresed as D Isc= (Isc at time t)2(Isc at time 0) and where D Rt=
(Rt at time t)2(Rt at time 0).
Dilution potentials were measured with modified Ringer’s
solution on the mucosal or serosal side of ex vivo treated tissues, and
the data from both conditions were pooled. In the modified
Ringer’s solution, 70 mM NaCl were replaced by 140 mM of
mannitol. Relative ion permeabilities were calculated by means of
the Goldman-Hodgkin-Katz equation and partial ion conductiv-
ities were determined using the respective ion concentrations of
normal Ringer’s.
Rats were used to compare the ex vivo effects of ETX in the small
intestine. The experimental protocol was essentially similar to that
used with mice except that loop length was 2.5 cm and the volume
injected was 0.3 ml at a concentration of 8,000 LD50. Intestines
were incubated during 4 hours.
Extravasation of plasma protein into the intestinal lumen
In vivo small intestine mucosal permeability was evaluated
following a modified version of Lange’s method [34]. Studies were
conducted in anesthetized mice and the experimental protocol was
essentialy similar to the method describe above for the intestinal
loop test. After 3 h of incubation with 1,000 LD50 of ETX or PBS
alone, a 0.1 ml of of the azo dye Evans blue (EB) in PBS (15 mg/ml)
was administered intravenously. The mice were eutanized 10
minutes later by cervical dislocation. The loops were dissected,
opened, and rinsed with acetylcysteine in order to remove the
adherent mucus layer. Each loop was weighed and incubated with
formamide for 24 hr to elute the amount of EB absorbed, which was
quantitated spectrophotometrically at 560 nm.
Histopathological analysis
Representative samples of intestinal tissues were taken imme-
diately after the end of each experiment. Samples were immersed
for 48 hs in 10% buffered formalin pH 7.2, after which they were
dehydrated through graded alcohols to xylene and embedded in
paraffin wax. Sections were cut at 4 mm and stained with
hematoxylin and eosin and examined by light microscopy.
Immunofluorescence detection of ETX binding to mouse
intestine
ETX (2,000 LD50/ml in Ringer’s solution) or control (Ringer’s
solution without ETX) was incubated during 20 minutes in
intestinal loops (ileum or colon) as described above. After
incubation, intestinal loops were excised and the intestinal content
was flushed with Ringer’s solution and tissues were immediately
frozen in Tissue-Tek OCT compound (EM Science). Air-dried
frozen sections of intestines were overlaid sequentially with goat
polyclonal antibody anti-ETX at 1/1,000, vol/vol, and fluoresce-
in-conjugated rabbit anti-goat (1/100, vol/vol; Sigma Aldrich Co)
for 1 h each. The toxin and antibodies were diluted in PBS.
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Control sections were applied by ussing the same buffer but
omminting the primary antibody.
Electron microscopy
Control and treated ileum segments of mice and rats were
removed immediately, flushed, cut into 0.5-cm rings, and fixed in
2% glutaraldehyde,1% paraformaldehyde in 0.1 mol/L phos-
phate buffer saline, pH 7.25, for 1 hour at 4uC. All of the
intestines were rinsed overnight at 4uC in 0.1 mol/L 4% sucrose
phosphate buffer, pH 7.5. Sections of intestinal rings 100 mm
thick were cut for localization of label. For HRP experiments, the
protocol was essentially similar to the method describe above for
the intestinal loop test, except that after a determined period of
time, loops were emptied and refilled with a HRP (mol wt 40 kDa)
solution of 4 mg in 0.25 ml Ringer and incubated during 15
minutes. After fixation, demonstration of peroxidase location was
achieved by incubating the sections in the dark for 20 minutes in
5 ml DAB (3, 39-diaminobenzidine) substrate medium (Sigma
Immuno Chemicals, St. Louis, MO). Sections were then rinsed in
Tris(hydroxymethyl) aminomethane buffer and postfixed in 1%
sodium cacodylate buffered osmium tetroxide for 60 minutes.
After dehydration with ethanol, the sections were treated with
propylene oxide and embedded in Epon polybed 812 (Poly/Bed;
Polysciences, Warrington, PA). The samples were first assessed by
lightmicroscopy with blue toluidine to select the areas for TEM
studies. Ultrathin sections were cut from selected areas [35].
Ultrathin sections were contrasted with 1% OsO4 and 1% uranyl
acetate, dehydrated and flatembedded in Durcupan. The sections
were contrasted with lead citrate, examined and photographed on
a Zeiss 109 electron microscope.
Statistical analysis
Statistical analysis was carried out using Statistix software
(version 2.0). One-way analysis of variance (ANOVA) and t-test
was used and assumed significance for a P value of ,0.05.
Throughout, descriptive statistics are reported as the mean6the
standard error of the mean (SEM).
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